c-JUN: a chromatin repressor that limits mesoderm differentiation in human pluripotent stem cells

Cell fate determination at the chromatin level is not fully comprehended. Here, we report that c-JUN acts on chromatin loci to limit mesoderm cell fate specification as cells exit pluripotency. Although c-JUN is widely expressed across various cell types in early embryogenesis, it is not essential f...

Full description

Saved in:
Bibliographic Details
Published inNucleic acids research Vol. 53; no. 3
Main Authors Zhang, Ran, Li, Guihuan, Zhang, Qi, Wang, Zhenhua, Xiang, Dan, Zhang, Xiaofei, Chen, Jiekai, Hutchins, Andrew P, Qin, Dajiang, Su, Huanxing, Pei, Duanqing, Li, Dongwei
Format Journal Article
LanguageEnglish
Published England Oxford University Press 24.01.2025
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Cell fate determination at the chromatin level is not fully comprehended. Here, we report that c-JUN acts on chromatin loci to limit mesoderm cell fate specification as cells exit pluripotency. Although c-JUN is widely expressed across various cell types in early embryogenesis, it is not essential for maintaining pluripotency. Instead, it functions as a repressor to constrain mesoderm development while having a negligible impact on ectoderm differentiation. c-JUN interacts with MBD3–NuRD complex, which helps maintain chromatin in a low accessibility state at mesoderm-related genes during the differentiation of human pluripotent stem cells into mesoderm. Furthermore, c-JUN specifically inhibits the activation of key mesoderm factors, such as EOMES and GATA4. Knocking out c-JUN or inhibiting it with a JNK inhibitor can alleviate this suppression, promoting mesoderm cell differentiation. Consistently, knockdown of MBD3 enhances mesoderm generation, whereas MBD3 overexpression impedes it. Overexpressing c-JUN redirects differentiation toward a fibroblast-like lineage. Collectively, our findings suggest that c-JUN acts as a chromatin regulator to restrict the mesoderm cell fate.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
The first three authors should be regarded as Joint First Authors.
ISSN:0305-1048
1362-4962
1362-4962
DOI:10.1093/nar/gkaf001